MediciNova, Inc.
Methods of treating ophthalmic disease/disorder or injury with ibudilast

Abstract:

This disclosure is directed to methods of treating ophthalmic disease/disorder or injury associated with neurodegenerative disease/disorder, such as progressive multiple sclerosis, or a neuro-ophthalmologic disorder in human patients using ibudilast.